Drawing for THE POWER OF PSMA

USPTO serial 79283785

THE POWER OF PSMA

Reviewed by CopyMark Law Group

Reg. 6366701Status 700Renewal
Filing date
Status date
Registration date
Jun 1, 2021
Examiner
PINO, DOMINIC ROBERT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with THE POWER OF PSMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew S. Ehard

Andrew S. Ehard Merchant & Gould P.C.P.O. Box 2910dockmpls@merchantgould.comMinneapolis, MN 55402-0910

Goods and services

ClassDescriptionStatusFirst use
005Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer; diagnostic kits comprising medical diagnostic radiopharmaceutical reagents and assays for testing of bodily fluids and tissue for use in detecting cancer and also consisting of vials, needleless drug delivery devices, swabable vial adaptors and medical syringes; drug delivery agents in the form of capsules that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticalsACTIVE—
010Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; medical apparatus for diagnostic radiopharmaceutical use; medical device for treating cancer; diagnostic imaging apparatus for medical use; applicators for pharmaceutical preparations, namely, drug delivery patches sold without medicationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 30, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 1, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 26, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 14, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 11, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 22, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 21, 2021FIMPFINAL DISPOSITION PROCESSED—
Sep 1, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 1, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 16, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 16, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 14, 2021GPNXNOTIFICATION PROCESSED BY IB—
Feb 24, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 24, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 10, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 9, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 9, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 9, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 21, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 21, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2020RFNTREFUSAL PROCESSED BY IB—
Jun 28, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 28, 2020RFRRREFUSAL PROCESSED BY MPU—
May 29, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 28, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2020DOCKASSIGNED TO EXAMINER—
May 2, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 28, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 27, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Apr 23, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance